Pharmacological Treatment of Attention Deficit Hyperactivity Disorder and its comorbidities - Part II
This program begins with an in-depth discussion of the use of stimulants for the treatment of Attention-deficit/hyperactivity disorder (ADHD), including dosing and side effects (both acute and long term). Next, the use of atomoxetine and the alpha-agonists (clonidine and guanfacine) are described. Tactics for dealing with side effects are discussed as well as how to deal with children who have comorbid ADHD and tic disorders. The controversial issue of treating explosive aggression in children with ADHD with second generation antipsychotics (SGA) is presented, with careful discussion of the significant side effects these agents have. The learner is cautioned to carefully balance risk and benefits and use these agents judiciously.
Objectives
- Effectively use various stimulant medications to treat Attention deficit hyperactivity disorder (ADHD)
- Understand long term effects of stimulant medications on growth as well as recent controversies in regarding the cardiovascular effects of stimulants
- Effectively use atomoxetine and guanfacine in the treatment of ADHD
- Determine when the use of second generation antipsychotics is appropriate to treat severe explosive aggression
To receive credit view the presentation. After the presentation has completed click on Questions for CME Credit. Fax the completed post-test and evaluation to Monica Trevino at 210-567-5677 by March 31, 2010. Credit will only be given if the form is completed and the post-test score is 70% or higher. Press the play button when you are ready to begin. Please allow 1 minute for presentation to load.
| Launch in external player |